Omega Healthcare Investors Q3 AFFO, Revenue Rise; Lifts 2026 Guidance
Omega Healthcare Investors reported Q3 adjusted FFO of $0.82 per share, beating estimates. Revenue also rose, and the company raised its 2026 guidance. The results reflect strong operational performance, according to the company.
How this was made

The 30-second read
Why it matters
A guidance lift typically changes forward valuation expectations for REITs, especially when paired with a reported quarterly AFFO figure.
Market read
Traders can update forward expectations for OHI based on the reported Q3 adjusted FFO and the stated 2026 guidance lift.
What to watch
For healthcare REITs, traders often discount AFFO quality and look for details on collections, operator health, and lease terms; those details are not present in the scraped excerpt.
Background
The article is a first-look on Omega Healthcare Investors’ Q3 performance, highlighting adjusted FFO and a 2026 guidance increase.
Ticker impact
Omega Healthcare Investors reported Q3 adjusted FFO of $0.82 per diluted share and lifted 2026 guidance, signaling updated earnings power for the REIT.
Likely upward pressure as the market prices in higher 2026 guidance following the Q3 adjusted FFO report.
The title explicitly states a Q3 AFFO/revenue rise and a 2026 guidance lift; the body snippet confirms the Q3 adjusted FFO figure, but the exact guidance numbers are not visible in the provided text.
Market effects
A guidance lift from a healthcare REIT can modestly improve sentiment around the sector’s earnings durability and rent/credit assumptions.
No clear regional-specific spillover indicated in the provided text.
Limited global relevance; primarily affects US healthcare REIT sentiment.
Counterpoint
The guidance lift may reflect timing or accounting effects, and without the specific 2026 range and assumptions, the market may still focus on underlying occupancy, rent escalators, or payer/credit risk.
Key entities
- companyOmega Healthcare Investors
US-listed healthcare REIT reporting Q3 adjusted FFO and lifting 2026 guidance.


